PackTalk is a blog for the Healthcare Packaging Industry

Do It Yourself Healthcare


Published on July 22, 2020

Chances are that you know someone who lives with a chronic condition that requires ongoing, regular treatment. Often, that treatment includes injections. More than ever, patients and families are finding themselves being transitioned from office visits to self-administration of injections at home.

As quickly as families, communities and industries adapt to changes in health care, particularly due to COVID-19 impacts, new changes arise. Cost containment, staffing shortages and safety protocols all play a role.  These factors have hastened the outsourcing of medical injections to home care vendors or, in many cases, the patient. For drug delivery system manufacturers, this growing sector of need is one to consider.

The advantages of self-administered medications are the convenience of managing at home and gaining a sense of control and confidence of the condition. If mastered, self-administration can also improve the patient’s health through high compliance. Downsides are poor training currently available to patients, the risk of self, family or other people of needlestick injuries due to improper safety or disposal, and fear that can lead to non-compliance and greater health risks.

This article takes a look at the emerging drug delivery device landscape, and the opportunity for innovators to seek new ways of accommodating patient capabilities and deficits, while increasing the safety, comfort and reducing risks of the self-administration market.

Read More.


Comments (0)

Related Articles

Cold Chain Packaging: Packaging Engineers Wanted

July 30, 2021

COVID-19 has put a public spotlight on the economic global demands and challenges related to cold chain drug supply and delivery. And while the growth trends in the world of cold chain packaging are not new, the focus is certainly heightened, leading...

Learn More

How Particulate Control Can Save or Destroy Your Next Launch

July 30, 2021

In the midst of a pandemic raging across the world, pharmaceutical companies are more and more alerted to the dangers and risks of drug product contamination. The recent FDA-ordered destruction of 60 million vaccine doses is one very prominent example. One...

Learn More

The Next Decade of Medical Packaging Belongs to China  – Part 3

July 30, 2021

The final part of our three-part series examines China’s role in the global supply chain for medical devices and packaging. A strong central government and experience managing pandemics led the country to a rapid rebound ahead of other economies.

Part 3:...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.